Key result
Belatacept cuts post-transplant diabetes risk ~35% versus calcineurin inhibitors in kidney transplant recipients.
Why the study?
Systematic evidence comparing post-transplant diabetes mellitus risk and overall safety between belatacept-based and calcineurin inhibitor-based regimens in kidney transplant recipients remained limited.
Does belatacept reduce the incidence of post-transplant diabetes mellitus in kidney transplant recipients compared to calcineurin inhibitors?
Systematic Review (n=1,737)
Yes
Does belatacept reduce the incidence of post-transplant diabetes mellitus in kidney transplant recipients compared to calcineurin inhibitors?
In kidney transplant recipients, belatacept-based immunosuppression significantly reduces the risk of new-onset post-transplant diabetes mellitus compared to calcineurin inhibitors, with both low and high-intensity regimens showing comparable protective effects.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Supports preferring belatacept over calcineurin inhibitors to reduce post-transplant diabetes risk in kidney recipients; confirms benefit across regimens.
Background The novel immunosuppressant belatacept demonstrates a unique mechanism of action that significantly improves renal function and reduces metabolic complications. However, systematic evidence comparing the risk of post-transplant diabetes mellitus (PTDM) and overall safety profiles between belatacept-based regimens and calcineurin inhibitor (CNI)-based protocols remains limited. This meta-analysis aims to synthesize high-quality evidence to determine the comparative efficacy of these two regimens in PTDM prevention and safety outcomes, thereby providing robust guidance for clinical decision-making. Methods We systematically searched PubMed, Cochrane Library, CNKI, and EMBASE for studies published until November 30, 2024, comparing belatacept versus calcineurin inhibitors (CNIs) regarding PTDM risk in kidney transplant recipients. The primary outcome was PTDM incidence. Following data extraction and quality assessment, we performed pairwise meta-analyses to compare PTDM risk between belatacept (either less intensive(LI) or more intensive (MI) regimen) and CNIs. Bayesian network meta-analysis (WinBUGS 1.4.3) was then conducted for indirect comparison between belatacept LI and MI regimens. Results The initial search yielded 3,206 records. After deduplication, title/abstract screening, and full-text evaluation, 6 studies involving 1,737 kidney transplant recipients were included in the final analysis. Compared with CNIs, belatacept demonstrated significant reductions in PTDM risk for both the LI (RR = 0.65, 95% CI 0.52-0.81, p<0.001; I²=30%) and MI (RR = 0.65, 95% CI 0.52-0.81, p<0.001; I²=30%) regimens. Bayesian network meta-analysis revealed no statistically significant difference between the LI and MI regimens. Conclusions This meta-analysis demonstrates that belatacept significantly reduces PTDM risk compared to CNIs, a finding consistent with previous studies. Notably, both LI and MI dosing regimens showed protective effects, suggesting that even low-intensity belatacept therapy could serve as a viable alternative to CNIs, particularly for patients requiring reduced immunosuppressive toxicity. Systematic review registration https://inplasy.com/ , identifier INPLASY202540041.
wang et al. (2026) conducted a systematic review in Adult kidney transplant recipients (≥18 years) with no simultaneous pancreas-kidney transplant, evaluated for post-transplant diabetes mellitus risk (n=1,737). Belatacept-based regimens (less intensive (LI) or more intensive (MI)) vs. Calcineurin inhibitors (CNIs) such as tacrolimus or cyclosporine was evaluated on Incidence of post-transplant diabetes mellitus (PTDM) as defined by standardized ADA/WHO criteria (RR 0.65, 95% CI 0.52-0.81, p=<0.001). Belatacept-based regimens reduced the risk of post-transplant diabetes mellitus by 35% compared to calcineurin inhibitors in adult kidney transplant recipients.
Synapse has enriched 10 related papers. Consider them for comparative context: